Bausch Health Companies Inc (NYSE: BHC) is 0.12% higher on its value in year-to-date trading and has touched a low of $3.96 and a high of $11.46 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The BHC stock was last observed hovering at around $8.08 in the last trading session, with the day’s loss setting it -0.05%.
Currently trading at $8.03, the stock is 19.57% and 26.82% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.85 million and changing -0.62% at the moment leaves the stock 5.73% off its SMA200. BHC registered -2.67% loss for a year compared to 6-month loss of -18.56%. The firm has a 50-day simple moving average (SMA 50) of $6.3416 and a 200-day simple moving average (SMA200) of $7.599.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 34.51% gain in the last 1 month and extending the period to 3 months gives it a 18.26%, and is 0.12% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.49% over the week and 3.99% over the month.
Bausch Health Companies Inc (BHC) has around 20270 employees, a market worth around $2.95B and $9.20B in sales. Fwd P/E is 1.93. Profit margin for the company is -5.12%. Distance from 52-week low is 102.78% and -29.93% from its 52-week high. The company has generated returns on investments over the last 12 months (-2.35%).
Bausch Health Companies Inc quarterly earnings per share for the current quarter are estimated at 1.04 with sales reaching $2.42B over the same period.The EPS is expected to grow by 4.10% this year, but quarterly earnings will post 8.30% year-over-year. Quarterly sales are estimated to grow 12.40% in year-over-year returns.
322.0 institutions hold shares in Bausch Health Companies Inc (BHC), with institutional investors hold 89.02% of the company’s shares. The shares outstanding are 365.24M, and float is at 320.79M with Short Float at 6.18%. Institutions hold 78.98% of the Float.
The top institutional shareholder in the company is ICAHN CARL C with over 34.72 million shares valued at $242.01 million. The investor’s holdings represent 9.466 of the BHC Shares outstanding. As of 2024-06-30, the second largest holder is PAULSON & CO. INC. with 26.44 million shares valued at $184.28 million to account for 7.208 of the shares outstanding. The other top investors are GOLDENTREE ASSET MANAGEMENT LP which holds 22.44 million shares representing 6.117 and valued at over $156.39 million, while NOMURA HOLDINGS INC holds 5.2808 of the shares totaling 19.37 million with a market value of $135.01 million.
Bausch Health Companies Inc (BHC) Insider Activity
The most recent transaction is an insider sale by Carson Seana, the company’s EVP, General Counsel. SEC filings show that Carson Seana sold 13,370 shares of the company’s common stock on Sep 06 ’24 at a price of $6.21 per share for a total of $83028.0. Following the sale, the insider now owns 0.44 million shares.
Still, SEC filings show that on Mar 04 ’24, Carson Seana (EVP, General Counsel) disposed off 6,313 shares at an average price of $9.80 for $61867.0. The insider now directly holds 499,905 shares of Bausch Health Companies Inc (BHC).
